CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk Information Technology iSERA Lifesciences Ltd

iSERA Lifesciences Ltd

BSE 534920 ISERA INE899M01020
Information Technology Information Technology IT - Software Computers - Software & Consulting

Filing rhythm · 60 trading days

9 filings · 2 material · busiest 2026-06-26 and 2026-08-07

What it files

Filings

9 in the window

  1. 14 August 2026

    Monitoring Agency

    Submission Of Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Quarter Ended June 30, 2026.

    We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended ....

    Company Update / Monitoring Agency Report View filing →

  2. 7 August 2026

    Board Outcome

    534920 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on ....

    Board Meeting / Outcome of Board Meeting View filing →

  3. 7 August 2026

    Results

    Un-Audited Financial Results For The Quarter Ended June 30, 2026

    We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

    Result / Financial Results View filing →

  4. 3 August 2026

    Board Meeting

    Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 7, August 2026 Inter-Alia, To Consider, Approve And Take On Record The Unaudited Financial Results Of The Company For The Quarter Ended On June 30, 2026

    Isera Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

    Board Meeting / Board Meeting View filing →

  5. 14 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    We are hereby submitting the Certificate issued by Share Transfer Agent of the Company, confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, ....

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 29 June 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Scrutinizer's Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26, 2026.

    AGM/EGM / Postal Ballot View filing →

  7. 26 June 2026

    Trading Window

    Closure of Trading Window

    We are hereby submitting the Closure of Trading Window for the Quarter June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  8. 26 June 2026

    General

    Filing Of Corrigendum To The Notice Of Postal Ballot Dated April 21, 2026 Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited).

    We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21, 2026, vide Corrigendum ....

    Company Update / General View filing →

  9. 11 June 2026

    Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) Held On Wednesday, June 11, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences ....

    Others / Outcome without intimation View filing →